Results 141 to 150 of about 33,868 (177)

“Humanizar”: aprendizajes sobre alteridad, salud y futuro en una experiencia de investigación compartida

open access: yesThe Journal of Latin American and Caribbean Anthropology, Volume 31, Issue 2, June 2026.
ABSTRACT The visit to Bogotá of a fééeneminaa (Muinane) friend, Célimo Nejedeka Jifichíu, and in particular, his work in researching and transmitting traditional health knowledge, offer the pretext to navigate the relationship between elements that at first glance seem distant from each other: indigenous imaginaries about otherness, their visions of ...
Giovanna Micarelli
wiley   +1 more source

Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post‐Mortem Studies

open access: yesNeuropathology and Applied Neurobiology, Volume 52, Issue 3, June 2026.
Graphical summary of post‐mortem brain tissue findings that differ between symptomatic and asymptomatic AD. Current evidence suggests reduced accumulation of Aβ and p‐tau oligomers, particularly at synapses, preserved neuronal and synaptic integrity and metabolic activity and a dynamic profile of glial and immune responses in ASYMAD.
Thiago Guilherme Rêgo Barros   +6 more
wiley   +1 more source

Hepatocyte PPARα Is Essential for Triglyceride-Lowering Effect of Pemafibrate. [PDF]

open access: yesInt J Mol Sci
Zhang Z   +7 more
europepmc   +1 more source

Chronic attenuation of brain leptin signalling is associated with early metabolic dysfunction in lean rats

open access: yesThe Journal of Physiology, Volume 604, Issue 12, Page 4717-4744, 15 June 2026.
Abstract figure legend Central leptin signalling blockade induces early metabolic dysfunction. Intracerebroventricular infusion of a leptin receptor antagonist (SLA) in rats disrupts hypothalamic leptin signalling, leading to reduced signal transducer and activator of transcription 3 (STAT3) activation, decreased Socs3 and Pomc expression, and ...
Cristina Pintado   +16 more
wiley   +1 more source

CXCL6 exacerbates metabolic dysfunction-associated steatohepatitis by suppressing LPIN1-mediated fatty acid oxidation in hepatocytes. [PDF]

open access: yesInt J Biol Sci
Cho YE   +14 more
europepmc   +1 more source

PFAS Toxicity: What's True, What's Not, and What Really Matters. [PDF]

open access: yesEnviron Sci Technol
DeWitt JC   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy